It has been suggested that resistance to leptin produce metabolic and inflammatory alterations in several tissues and organs, including the liver, spleen and heart, therefore leptin resistance contributes to the risk for obesity-related comorbidities [23]. This evidence concerns the gene LEP and obesity disorder.